References
Chan, M. (2015, March 10). From crisis to sustainable development: Lessons from the Ebola outbreak. https://www.who.int/director-general/speeches/detail/from-crisis-to-sustainable-development-lessons-from-the-ebola-outbreak. Accessed 3 Nov 2023
Duong, D., & Vogel, L. (2022). Why is WHO pushing back on a Health Canada–approved Medicago SARS-CoV-2 vaccine? Canadian Medical Association Journal, 194(13), E504–E505. https://doi.org/10.1503/cmaj.1095992
Kirby, T. (2023). Philip Morris ejected from Canadian vaccine collaboration. The Lancet Respiratory Medicine, S221326002300053X. https://doi.org/10.1016/S2213-2600(23)00053-X
Mathew, M., & Thomas, J. (2022). Tobacco-based vaccines, hopes, and concerns: A systematic review. Molecular Biotechnology, 1–29. https://doi.org/10.1007/s12033-022-00627-5
Nardi, C. (2023, November 3). Ministry reveals $150M PHAC loss was from “unfulfilled” COVID-19 vaccine deal with Quebec company Medicago. National Post. https://nationalpost.com/news/canada/phac-mysterious-loss-vaccine-contract. Accessed 3 Nov 2023
NBC News. (2014, August 5). Ebola treatment: How Big Tobacco and the military came together. NBC News. https://www.nbcnews.com/storyline/ebola-virus-outbreak/ebola-treatment-how-big-tobacco-military-came-together-n173311. Accessed 3 Nov 2023
Sayburn, A. (2014). WHO gives go ahead for experimental treatments to be used in Ebola outbreak. British Medical Journal, 349, g5161. https://doi.org/10.1136/bmj.g5161
World Health Assembly. (2016). Framework of engagement with non-State actors (FENSA) (WHA69.10; Sixty-Ninth World Health Assembly). https://apps.who.int/gb/ebwha/pdf_files/wha69/a69_r10-en.pdf. Accessed 3 Nov 2023
World Health Organization. (2003). WHO Framework Convention on Tobacco Control (FCTC). https://fctc.who.int/publications/i/item/9241591013. Accessed 3 Nov 2023
World Health Organization. (2022). Therapeutics for Ebola virus disease. World Health Organization. https://www.who.int/publications/i/item/9789240055742. Accessed 3 Nov 2023
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Houston, A.R. Medicago saga highlights need for WHO clarity on medical R&D involving tobacco. Can J Public Health 115, 67–68 (2024). https://doi.org/10.17269/s41997-023-00839-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.17269/s41997-023-00839-5